Shigellosis: high rates of antibiotic resistance necessitate new treatment recommendations.

Brown, Jeremy; Willcox, Simon J; Franklin, Neil; Hazelton, Briony; O'Sullivan, Matthew V N

Brown, Jeremy; Willcox, Simon J; Franklin, Neil; Hazelton, Briony; O'Sullivan, Matthew V N.

Afiliação

Brown J; Centre for Infectious Disease and Microbiology - Public Health, Westmead Hospital, Sydney, NSW simon.willcox@doh.health.nsw.gov.au.
Willcox SJ; NSW Health, Sydney, NSW.
Franklin N; NSW Health, Sydney, NSW.
Hazelton B; Centre for Infectious Disease and Microbiology - Public Health, Westmead Hospital, Sydney, NSW.
O'Sullivan MV; Centre for Infectious Disease and Microbiology - Public Health, Westmead Hospital, Sydney, NSW.

Med J Aust ; 204(7): 261, 2016 Apr 18.

Article em En | MEDLINE | ID: mdl-27078594

Assuntos

Disenteria Bacilar/tratamento farmacológico; Austrália; Azitromicina/uso terapêutico; Farmacorresistência Bacteriana; Humanos

Buscar no Google

Imprimir

XML

PubMed Links

Base de dados: MEDLINE Assunto principal: Disenteria Bacilar Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Med J Aust Ano de publicação: 2016 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links